Effects of Glucagon-Like Peptide 1 on Appetite and Body Weight: Focus on the CNS
Change history 19 November 2024 In the version of this article initially published online, earlier, incorrect versions of the Source data files were posted and are now replaced in the online version of the article
The cannabis industry has discussed this widespread use of GLP-1 weight-loss drugs as a disruption
It is the moment to ask how aggressive the plan should be based on your weight, family history, blood sugar pattern, and overall health profile
As the body adapts to GLP-1based signaling, appetite reduction and weight change may slow over time
Your provider will review your dose, side-effect history, blood sugar, insurance coverage, and appropriate starting dose for tirzepatide before making the change